IRS2 and myeloproliferative neoplasm: IRS2 gene expression is also higher in CD34+ cells from patients with ET, when compared to healthy donors, and from patients with JAK2V617F MPN compared to JAK2WT patients, indicating that the JAK2V617F mutation is associated with increased IRS2 expression.